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Abstract
Purpose The purpose of this study was to examine the relationship between physical impairments, quality of life and disability in
patients following neck dissection, with consideration of patient and clinical characteristics.
Methods Cross-sectional study of patients < 5 years after neck dissection for head and neck cancer. Quality of life and self-
reported disability were measured with the Neck Dissection Impairment Index, Quick Disabilities of the Arm, Shoulder and
Hand, and Neck Disability Index. Active neck and shoulder range of motion and isometric muscle strength were also assessed.
Generalised linear modelling was used to explore relationships between variables.
Results Eighty-four participants (68% male, median age 61 years) demonstrated reduced quality of life (median (interquartile
range) score = 76 (49, 93) from 0 (worst) to 100 (best)), and mild levels of upper limb (14 (2, 32)) and neck disability (14 (6, 28))
(from 0 (best) to 100 (worst)). Bilateral neck dissection was associated with reduced quality of life (coeff (95% CI) =
− 12.49 (− 24.69, − 0.29)). Post-operative chemoradiation therapywas associatedwith reduced quality of life (− 21.46 (− 37.57,
− 5.35)) and neck disability (0.71 (0.10, 1.32)). Measures of shoulder flexibility or strength were associated with quality of life and
self-reported disability.
Conclusions Quality of life and musculoskeletal disability after neck dissection are associated with factors frommultiple domains
including physical motor function and treatment modality.
Implications for Cancer Survivors Having reduced shoulder flexibility or strength is related to functional deficits and quality of
life after neck dissection for head and neck cancer.
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Introduction
Patients diagnosed with head and neck cancer (HNC) are
treated with surgery, radiation therapy (XRT) and/or chemo-
therapy, with the aim of maximising survival whilst preserv-
ing physical form and function [1]. Treatment decisions can be
influenced by the potential for short- and long-term side ef-
fects. Surgery commonly involves the removal of structures
such as the tongue or temporomandibular joint. The resulting
side effects (dysarthria, dysphagia) negatively impact upon
health-related quality of life (HRQOL) [2]. Neck dissection
(ND) can result in shoulder impairment and an associated
reduction in HRQOL. Loss of active range of motion
(AROM) at the shoulder [3] and neck [4], as well as impair-
ments to sensation [5] and strength [6] can occur following
ND. Patient-reported outcome measures specific to both HNC
[7] and ND [8] have confirmed the negative impact this pro-
cedure can have on HRQOL. In addition, the presence of
subjectively [9] and objectively [10] measured shoulder dis-
ability has been associated with the type of ND performed.
Radical ND (RND) removes the sternocleidomastoid mus-
cle, the internal jugular vein and the accessory nerve as well as
lymph nodes [11–13]. Considering the accessory nerve inner-
vates the trapezius and sternocleidomastoid muscles, it is not
surprising that patients can present with altered shoulder girdle
function. However, impairmentsmay still be present evenwhen
the nerve has been preserved [14]. Physical function could po-
tentially be impaired by soft tissue trauma, subsequent scaring
and post-surgical pain regardless of whether the accessory
nerve was spared during ND. These side effects could be wors-
ened with the addition of (chemo)radiation therapy ((C)XRT).
Other factors that may contribute to this physical dysfunction
include disuse and deconditioning, and psychosocial factors
such as pain-related fear and anxiety. What remains unknown
at this point is whether a relationship exists between the degree
of physical impairment and reported HRQOL and disability,
when the influence of other factors such as the extensiveness
of the surgery and the addition of (C)XRT are also considered.
The aim of this study was to examine the relationship be-
tween physical function, HRQOL and disability in patients
from 6 months to 5 years of ND for HNC, with due consider-
ation of the effect of patient and clinical characteristics. It was
hypothesised that more severe physical impairment would be
associated with patient reports of poorer HRQOL and greater
levels of neck and shoulder disability.
Methods
Study design, setting, participants and procedure
This cross-sectional study was conducted at two tertiary hos-
pitals in Brisbane, Australia. Patients who received ND for
HNC between 2009 and 2014 identified from hospital admin-
istrative records were eligible for this study. Invitations to par-
ticipate were mailed to eligible patients, and responders were
screened against exclusion criteria: under 18 years of age at
surgery; pre-existing ipsilateral shoulder or neck pain or injury
in the 6 months prior to surgery severe enough to limit daily
function; inability to provide informed consent (e.g. due to
cognitive impairment). All participants attended one assess-
ment at their hospital with a physiotherapist (EG) during which
all physical and questionnaire-based outcomes were assessed.
The questionnaire-based outcomes were measures of HRQOL
and self-reported disability, which prompted participants to
reflect on their lives in the 1–4 weeks prior to responding to
items. Ethical approval was obtained from the institutional
human research ethics committees. All participants provided
written informed consent. Standard post-operative clinical care
at the participating hospitals included the prescription of shoul-
der and neck range of motion exercises immediately after sur-
gery. Referral for ongoing outpatient physical therapy was
made if shoulder pain or movement impairment was identified
immediately after surgery, during post-operative XRT or at
other times when considered appropriate by the treating team.
Dependent variables—measures of HRQOL
and self-reported disability
Neck Dissection Impairment Index (NDII)
The NDII is a region-specific measure of HRQOL for patients
following ND [15]. This patient-reported outcome measure
produces a summary score ranging from 0 (worst HRQOL)
to 100 (best HRQOL) and reflects the extent to which indi-
viduals experience symptoms, difficulty performing tasks and
restrictions to work, social or leisure activities as a result of
ND. The NDII has evidence to support its internal consistency
and convergent validity against the Constant Shoulder Score
and the Short Form-36 (SF-36) [15, 16] .
Quick Disabilities of the Arm, Shoulder and Hand
(QuickDASH)
The QuickDASH is an 11-item patient-reported outcomemea-
sure of functional limitations and symptoms (pain, pins and
needles) in the upper limb [17]. The scores range from 0 (no
impairment) to 100 (total impairment). The QuickDASH has
shown both internal consistency and test–retest reliability in
women with breast cancer [18] and construct validity in an
orthopaedic population [17].
Neck Disability Index (NDI)
The 10-item NDI is a measure of pain-related neck disability.
Questions relate to the impact of neck pain on tasks such as
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reading, driving andwork, as well as the presence of headaches
[19, 20]. The score is expressed as a percentage from 0% (no
impairment) to 100% (total impairment) [21]. The NDI has
evidence to support test–retest reliability, internal consistency,
construct validity and concurrent validity with the McGill Pain
Questionnaire in populations with neck pain [19, 20].
Explanatory variables—physical performance
measures:
Resting scapular position
The scapula was defined as being upwardly (> 0°) or down-
wardly (< 0°) rotated in the plane of the scapula, with 0°
representing a neutral position, during relaxed upright stand-
ing with the arms by the trunk [22]. A bubble inclinometer
(Baseline, Fabrication Enterprises Inc., USA) was placed on
the spine of the scapula to record the angle of rotation. The
average of three repetitions was recorded bilaterally and the
mean used for analysis.
Shoulder and neck active range of motion (AROM)
Three positions were used for measuring AROM: standing
(bilateral shoulder flexion, abduction and hand-behind-back),
supine lying (bilateral neck rotation and shoulder external ro-
tation) and upright sitting (neck flexion and extension). Hand-
behind-back is a combination of shoulder internal rotation,
extension and adduction, and was graded on a scale from 0
(hand reaches within 5 cm of the opposite scapula) to 4
(cannot move the hand behind the trunk) [23]. All other
AROMmeasurements were taken with a bubble inclinometer.
These measurements have demonstrated moderate to high
test–rest and intra-tester reliability [24–27]. Three practice tri-
als for each movement were conducted, after which three rep-
etitions were recorded and the mean used for analysis.
Shoulder and neck maximal isometric strength
Isometric neck and shoulder strength was measured with a
dynamometer (BFG, Mecmesin, USA) attached to a rigid
frame with two adjustable components. Isometric neck flexion
and extension strength were tested with the participant sitting
on a rigid frame, their trunk supported by an adjustable back-
rest and a belt across their chest (Fig. 1a, b). The adjustable
resistance armwas positioned so that the dynamometer resisted
neck flexion via the forehead and extension via the occiput.
Participants were instructed to push with their forehead
(flexion) or occiput (extension) against the resistance in an
arc towards the floor in front (flexion) or behind (extension)
them. Isometric shoulder flexion strength was measured with
participants in standing, their back resting against a wall and
their testing arm in line with the trunk (neutral) (Fig. 1c). The
resistance pad of the dynamometer was applied to the anterior
distal humerus just above the elbow crease with the elbow
extended and forearm in full supination. Participants were
instructed to perform their maximal effort into shoulder flexion
against the dynamometer resistance pad.
Standard verbal encouragement was given during all
strength tests, which were discontinued if pain was reported.
Two submaximal contractions were conducted as a warm-up
followed by up to three experimental repetitions of maximal
effort, with a 1 min seated rest between repetitions. A third
repetition was performed if the second repetition exceeded the
first to ensure the maximal effort had been achieved. The
maximum value recorded was used for analyses. The order
Fig. 1 The apparatus for the measurement of isometric muscle strength
consisted of a specially designed ridged frame attached to a dynamometer
with the participant positioned in sitting for a neck extension and b neck
flexion, and standing for c shoulder flexion
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of strength tests (neck, shoulder) was randomised across all
participants to control for any effects of fatigue. At the shoul-
der, the non-operated arm was tested first to familiarise the
participant with the test. Previous studies have shown isomet-
ric strength tests to be reliable for both the neck (ICC 0.94–
0.99) [28, 29] and shoulder (0.79–0.99) [30, 31].
Explanatory variables—participant and clinical
characteristics
Height and weight were self-reported by participants. Medical
records were reviewed for other patient (e.g. age at time of
surgery), tumour (e.g. staging) and treatment-related (e.g. ad-
juvant treatment) information. Type of ND was based on the
classification system developed by the American Head and
Neck Society [11–13]. Themost recent NDwas use to classify
patients by type of ND if there was a history of more than one.
Each participant was described as having an affected (ipsilat-
eral to surgery) and unaffected (contralateral to surgery) side.
For participants with a history of bilateral ND, the affected
side was considered as either the side with the more extensive
ND (if procedures were different) or most restricted shoulder
AROM (if procedures were the same).
Data analysis
All statistical analyses were conducted using Stata (Stata
Statistical Software, Release 13; StataCorp LP, College,
Station, TX). Shapiro–Wilk tests and visual inspection with
histograms indicated the data were not normally distributed.
Therefore, Kruskal–Wallis tests were used to investigate po-
tential differences in questionnaire outcomes between ND
subgroups. Generalised linear models were used to examine
whether physical impairment, patient, tumour and treatment-
related variables were associated with either (1) NDII, (2)
QuickDASH or (3) NDI. An identity link function was select-
ed for the NDII model and log link functions were selected for
the QuickDASH and NDI models to optimise model fit. Age,
sex, body mass index, type of ND, time since surgery and
accessory nerve status were included as potential explanatory
variables in each model. In addition, the least absolute shrink-
age and selection operator (LASSO) technique was used to
guide variable selection for inclusion of other potential ex-
planatory variables (to minimise risk of over-fitting) for the
three respective generalised linear models. The additional var-
iables considered during the LASSO technique for inclusion
were affected scapular resting position, affected shoulder
AROM (all directions), neck AROM (all directions), affected
shoulder flexion strength (measured in kilogramme/force
(kgf)), shoulder strength ratio (affected/unaffected), neck flex-
ion and extension strength (kgf), neck strength ratio (cervical
flexion/extension), T stage, N stage, tumour pathology, tu-
mour location, history of ND and use of adjuvant therapy.
Robust standard errors were used to account for the potential
influence of heteroskedasticity in the generalised linear
models [32, 33]. Variance inflation factors were used to rule
out the potential presence of multicollinearity. To examine the
potential influence of using the aforementioned LASSO vari-
able selection technique in comparison to the selection of var-
iables from a series of univariate regressions, a sensitivity
analysis was conducted for each of the models. Variables with
a p value of ≤ 0.20 in the univariate regressions were included
within a generalised linear model and model outputs (coeffi-
cients and confidence intervals for significant findings) were
then compared to the output from the primary analyses (and
were consistent with the primary analysis and therefore have
not been presented).
Results
A total of 87 patients participated in this study: 44 (51%)
following unilateral SND, 24 (28%) following unilateral
MRND, 16 (18%) following bilateral ND and 3 (3%) follow-
ing unilateral RND. Participants with RND were not included
in analyses due to the small number (n = 3) leaving 84 partic-
ipants in the study cohort (Table 1). The median (Q1, Q3) age
at the time of surgery was 61 (48, 69) years. Time since sur-
gery ranged from a minimum of 205 days to a maximum of
2199 days, with median (Q1, Q3) values of 1277 (700, 1580)
days. The majority of participants were male (n = 57, 68%).
The largest group by pathology was squamous cell carcinoma
(n = 48, 57%). Fifty-one participants (61%) were treated with
XRT, 49 (96%) post-operatively, and 22 (26%) received che-
motherapy, most of whom received it in conjunction with
XRT (n = 17, 20%).
A summary of patient reported NDII, QuickDASH and NDI
scores is presented Table 2 per type of ND with the distribution
of scores for each outcome measure displayed in Fig. 2. In
summary, reduced HRQOL (NDII) and mild levels of upper
limb (QuickDASH) and neck disability (NDI) were present
among a substantial proportion of participants. Fifty participants
(60%) reported a QuickDASH score of ≥ 10, suggesting they
were experiencing meaningful dysfunction. A similar number
(n = 48, 57%) had at least a mild level of neck disability (NDI >
10%). Of those with neck disability, 29 (35%), 11 (13%) and 7
(8%) experienced mild, moderate or severe levels of neck dis-
ability, respectively. There were no significant differences in
NDII, QuickDASH or NDI scores between type of ND.
Median active range of motion and strength values were
lower on participants’ affected side than unaffected side and
are summarised in Table 3. The results of the generalised
linear modelling for the (1) NDII, (2) QuickDASH and (3)
NDI are presented in Table 4.
Reduced HRQOL was associated with reduced shoulder
flexion AROM (coeff (95% CI) = 0.56 (0.24, 0.86)), being
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Table 1 Cohort characteristics
Clinical or treatment-related factor Whole ND cohort Unilateral SND Unilateral MRND Bilateral ND
N (%) N (%) N (%) N (%)
Participants 84 (100%) 44 (52%) 24 (29%) 16 (19%)
Age at surgery, years
Median (Q1, Q3) 61 (48, 69) 62 (47, 71) 58 (49, 66) 57 (49, 68)
Length of stay, daysa
Median (Q1, Q3) 6 (5, 15) 6 (5, 12) 6 (5, 8) 13 (8, 18)
Time since surgery, days
Median (Q1, Q3) 1277 (700, 1580) 1264 (792, 1550) 1305 (611, 1589) 1157 (590, 2038)
Total theatre time, h
Median (Q1, Q3) 6.1 (4.7, 10.4) 6.4 (4.3, 9.5) 5.1 (4.5, 6.2) 10.7 (6.9, 12.9)
Body mass index, kg/m2
Median (Q1, Q3) 26 (23, 29) 27 (23, 29) 25 (23, 28) 25 (21, 31)
Sex—male 57 (68%) 28 (64%) 18 (75%) 11 (69%)
History of > 1 ND 11 (13%) 7 (16%) 1 (4%) 3 (19%)
Level V involved in the ND 41 (49%) 7 (16%) 24 (100%) 10 (63%)
Accessory nerve sacrificed 5 (6%) 0 (0%) 3 (13%) 2 (13%)
SCM resected in part or whole 13 (15%) 2 (5%) 6 (25%) 5 (31%)
IJV resected in part or whole 11 (13%) 2 (5%) 6 (25%) 3 (19%)
History of recurrent disease 38 (45%) 20 (45%) 13 (54%) 5 (31%)
Disease pathology
SCC 48 (57%) 25 (57%) 13 (54%) 10 (63%)
PTC 17 (20%) 10 (23%) 1 (4%) 6 (37%)
Melanoma 11 (13%) 5 (11%) 6 (25%) 0 (0%)
Other 8 (10%) 4 (9%) 4 (17%) 0 (0%)
Location of tumour/disease
Mucosal 31 (37%) 16 (36%) 7 (29%) 8 (50%)
Neck nodal metastases 28 (33%) 13 (30%) 13 (54%) 2 (13%)
Cutaneous 14 (17%) 9 (20%) 4 (17%) 1 (6%)
Thyroid 11 (13%) 6 (14%) 0 (0%) 5 (31%)
T stage
T0 8 (10%) 3 (7%) 5 (21%) 0 (0%)
T1 7 (8%) 3 (7%) 2 (8%) 2 (13%)
T2 11 (13%) 8 (18%) 2 (8%) 1 (6%)
T3 5 (6%) 2 (5%) 0 (0%) 3 (19%)
T4 15 (18%) 5 (11%) 4 (17%) 6 (38%)
Tis 1 (1%) 0 (0%) 1 (4%) 0 (0%)
Tx 4 (5%) 2 (5%) 2 (8%) 0 (0%)
Not available 33 (39%) 21 (48%) 8 (33%) 4 (25%)
N stage
N0 11 (13%) 9 (21%) 1 (4%) 1 (6%)
N1 12 (14%) 6 (14%) 2 (8%) 4 (25%)
N2 27 (32%) 8 (18%) 12 (50%) 7 (44%)
N3 1 (1%) 0 (0%) 1 (4%) 0 (0%)
rN+ 30 (36%) 20 (45%) 6 (25%) 4 (25%)
rN0 3 (4%) 1 (2%) 2 (8%) 0 (0%)
XRT
No XRT 33 (39%) 19 (43%) 8 (33%) 6 (38%)
Post-operative 60 Gy/30# 15 (18%) 6 (14%) 5 (21%) 4 (25%)
Post-operative > 60 Gy/30# 8 (10%) 3 (7%) 3 (13%) 2(13%)
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unable to pass the hand behind the trunk (category 4 hand-be-
hind-back) (− 37.21 (− 64.19, − 10.22)), reduced shoulder flex-
ion strength ratio (27.19 (11.72, 42.67)), younger age at surgery
(0.85 (0.56, 1.13)), greater BMI (− 1.84 (− 2.82, − 0.85)),
having undergone a bilateral ND (− 12.49 (− 24.69, − 0.29)),
having a history of > 1 ND (− 17.00 (− 29.37, − 4.62)) and hav-
ing ND with concurrent CXRT (− 21.46 (− 37.57, − 5.35)).
Higher levels of upper limb disability were associated with
reduced hand-behind-back AROM (category 1 hand-behind-
back coeff (95% CI) = 0.47 (0.04, 0.89); category 4 1.08
(0.49, 1.66)) and decreased shoulder flexion strength ratio
(− 1.01 (− 1.70, − 0.33)). Lower levels of upper limb disability
were associated with having no T stage available (compared
with T0) (coeff (95%CI) = − 0.76 (− 1.36, − 0.16)). Being of a
younger age at surgery was trending towards a significant
relationship with lower levels of upper limb disability (coeff
(95% CI) = − 22.78 × 10−3 (− 46.97 × 10−3, 1.42 × 10−3);
p = 0.07).
High self-reported neck disability was significantly associ-
ated with reduced AROM shoulder flexion (coeff (95% CI) =
Table 1 (continued)
Clinical or treatment-related factor Whole ND cohort Unilateral SND Unilateral MRND Bilateral ND
N (%) N (%) N (%) N (%)
Post-operative < 60 Gy/30# 11 (13%) 6 (14%) 4 (17%) 1(6%)
Post-operative dose unknown 11 (13%) 6 (14%) 3 (13%) 2 (13%)
≥ 2 episodes of XRT 4 (5%) 3 (7%) 0 (0%) 1 (6%)
Pre-operative XRT 2 (2%) 1 (2%) 1 (4%) 0 (0%)
Chemotherapy
No chemotherapy 62 (74%) 35 (80%) 14 (58%) 13 (81%)
Cisplatin 10 (12%) 4 (9%) 6 (25%) 0 (0%)
Other 12 (14%) 5 (11%) 4 (17%) 3 (19%)
Adjuvant treatment
Surgery only 30 (36%) 18 (41%) 6 (25%) 6 (38%)
Surgery + XRT 32 (38%) 17 (39%) 8 (33%) 7 (44%)
Surgery + concurrent CXRT 17 (20%) 7 (16%) 7 (29%) 3 (19%)
Otherb 5 (6%) 2 (5%) 3 (13%) 0 (0%)
Location of surgery conducted concurrently with ND
ND only 10 (23%) 12 (15%) 1 (6%) 23 (27%)
Oral cavity, oropharynx 8 (18%) 3 (25%) 5 (31%) 16 (19%)
Pharynx and larynx 6 (14%) 4 (33%) 3 (19%) 13 (15%)
Face and skin 15 (34%) 4 (33%) 1 (6%) 20 (24%)
Neckc 6 (14%) 4 (33%) 8 (50%) 18 (21%)
Reconstruction 9 (2%) 3 (33%) 7 (44%) 19 (23%)
Skull base 2 (5%) 0 (0%) 0 (0%) 2 (2%)
Outside head/neck region 1 (2%) 0 (0%) 0 (0%) 1 (1%)
ND neck dissection, SND selective neck dissection,MRNDmodified radical neck dissection, SCM sternocleidomastoid, IJV internal jugular vein, SCC
squamous cell carcinoma, PTC papillary thyroid carcinoma, XRT radiation therapy, CXRT chemoradiation therapy
a Length of stay as an inpatient following ND surgery
b Surgery with chemotherapy only or surgery with chemotherapy and XRT delivered separately
c For example, thyroidectomy, tracheostomy
Table 2 Results from the three
primary outcomes: Neck
Dissection Impairment Index
(NDII), Quick Disabilities of the
Arm, Shoulder and Hand
(QuickDASH), and Neck
Disability Index (NDI)
Primary outcome Whole cohort
Median (Q1, Q3)
Unilateral SND
Median (Q1, Q3)
Unilateral MRND
Median (Q1, Q3)
Bilateral ND
Median (Q1, Q3)
NDII 76 (49, 93) 83 (65, 94) 74 (39, 93) 64 (28, 84)
QuickDASH 14 (2, 32) 13 (2, 30) 11 (1, 33) 18 (7, 52)
NDI 14 (6, 28) 16 (6, 27) 12 (2, 34) 9 (8, 40)
NDII Neck Dissection Impairment Index, QuickDASH Quick Disabilities of the Arm, Shoulder and Hand, NDI
Neck Disability Index, SND selective neck dissection,MRNDmodified radical neck dissection,ND neck dissection
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− 0.01 (− 0.02, 0.00)), a younger age at surgery (− 0.05
(− 0.07, − 0.03)), greater BMI (0.05 (0.01, 0.08)), having
ND with concurrent CXRT (0.71 (0.10, 1.32)) and three of
the categories for restricted shoulder hand-behind-back
movement (e.g. category 4 2.36 (1.05, 3.66)). Two of the
T stage categories were significantly associated with neck
disability (with reference to T0): having T1 disease was
associated with greater neck disability (coeff (95% CI) =
0.62 (0.24, 1.01)), and having T4 disease was associated
with less neck disability (− 0.49 (− 0.88, − 0.10)).
Accessory nerve sacrifice was associated with less neck
disability (coeff (95% CI) = − 0.92 (− 1.50, − 0.33)); how-
ever, this finding is likely spurious and should be
interpreted with caution as the number of individuals with
accessory nerve sacrifice was small (n = 5).
Discussion
This study was successful in identifying associations be-
tween physical function, HRQOL and disability in patients
within 5 years of ND for HNC. Bilateral ND (in comparison
to unilateral SND) and post-operative concurrent CXRT (in
comparison to no adjuvant treatment) were associated with
poorer HRQOL. In addition, receiving concurrent CXRT
was also associated with greater neck disability. In contrast,
there was no evidence for an association between type of
ND and either upper limb or neck disability. A range of
other patient-, tumour- and treatment-related factors were
associated with reduced HRQOL, upper limb disability or
neck disability. This evidence suggests the reasons for re-
duced HRQOL or upper limb and neck disability following
ND are multi-factorial. Patients receiving bilateral ND or
post-operative concurrent CXRT, or with a history of more
than one ND, may require close monitoring for signs of
poor recovery of HRQOL and referral to appropriate reha-
bilitation health professionals to address underlying
concerns.
Shoulder range of motion plus strength were associated
with upper limb disability in the present study. Restricted
hand-behind-back AROM, rather than abduction, was associ-
ated with greater upper limb disability. Hand-behind-back is a
movement essential for many key tasks of daily living (e.g.
showering, drying and dressing oneself). However, it is not
commonly a focus of physical rehabilitation programmes
post-ND [34, 35]. Instead, programmes may primarily focus
on shoulder abduction, both as an outcome measure and a
target for therapy [34]. The present study also found an asso-
ciation between reduced shoulder strength and increased up-
per limb disability. Previously, progressive resistance exercise
training with machine weights has been shown to improve
upper body strength, which was then determined to be asso-
ciated with better shoulder function [34]. Whilst both the pres-
ent study and this study of exercise training show association
and not causation, these results could support the importance
of retraining muscular strength during rehabilitation after ND,
Fig. 2 Results for the three primary outcome measures: a Neck
Dissection Impairment Index (0 worst HRQOL, 100 best HRQOL); b
Quick Disabilities of the Arm, Shoulder and Hand (0 no upper limb
impairment, 100 total upper limb impairment); c Neck Disability Index
(0% no neck impairment, 100% total neck impairment)
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but also suggest hand-behind-back range ought to be
considered.
Significant associations with the NDII identified in the
present study have some similarities to previous research
[8]. Gallagher and colleagues [8] assessed 167 patients at a
median of 28.2 (range, 12–84) months following ND. NDII
scores were significantly worse in patients who received
MRND compared with SND, which was not the case in
the present study. There was a small difference between
the studies in the use of chemotherapy (present study,
24% vs. Gallagher, 16%) and XRT (present study, 61%
vs. Gallagher, 75%). Despite this, both studies found asso-
ciations between these adjuvant treatments and reduced
HRQOL. Together, these findings highlight the potential
for impairments to HRQOL to persist several years after
ND, and for surgery, XRT and chemotherapy to have indi-
vidual and cumulative effects on HRQOL. The presence of
an association between younger age and increased neck
disability (as well as quality of life (NDII) in this cohort)
seems counter-intuitive, but may be related to the history of
malignancy within this cohort (i.e. younger patients may
not have age-related chronic diseases that have previously
impaired HRQOL; therefore, the diagnosis of a life-limiting
illness has a greater negative effect on their HRQOL com-
pared with older patients). Interestingly, an association was
present between T4 disease (compared with T0 disease) and
lower levels of neck disability. The authors are unable to
explain this observation. One theoretical and untested
explanation may be that having received a poor prognosis
at diagnosis, patients with T4 disease who survive their
cancer may be inclined to self-report positive outcomes as
a reflection of their pleasure in being alive.
In addition to an association with HRQOL, undergoing
concurrent CXRT was also significantly associated with
neck disability. Soft tissue side effects can occur following
XRT, including fibrosis [36] and lymphoedema [37], al-
though the evidence for an exacerbation of accessory nerve
injury by XRT beyond ND has been inconsistent: some
studies reported no additional burden [38–43], while others
reported lower objective or subjective findings in patients who
had ND and XRT [44, 45]. The most common chemotherapy
agent in the present study was cisplatin, a drug delivered with
XRT to patients with locally advanced disease to increase
overall survival [46]. Known side effects of cisplatin and
XRT include dysphagia, xerostomia and ototoxicity [47].
Fatigue is also a side effect of cisplatin [48]. Cancer-related
fatigue is the most commonly reported side effect across all
cancers [49]. While fatigue was not directly measured (as it
was beyond the scope of the present study aims), it is plausible
that cancer-related fatigue contributed to poorer HRQOL
scores, particularly among people who had received cisplatin.
Further prospective studies that consider XRT dose and drug
type may shed light on how adjuvant treatment can impact
upon musculoskeletal functioning.
Table 3 Results from the
physical measures of scapular
resting position, neck and
shoulder AROM and isometric
muscle strength
Physical outcome measure Participants (n = 84) Median (Q1, Q3)
Affected side Unaffected side Total range
Scapular resting position (°) − 2 (− 8, 4) 0 (− 4, 2)
Shoulder AROM (°)
Shoulder flexion 150 (130, 162) 160 (144, 166)
Shoulder abduction 145 (119, 155) 153 (139, 165)
Shoulder external rotation 45 (35, 60) 50 (40, 60)
Hand-behind-back 35 (42%)a 29 (35%)a
Neck AROM (°)
Neck rotation 65 (54, 75) 63 (51, 70) 125 (110, 142)
Neck flexion 54 (45, 60)
Neck extension 48 (40, 55)
Affected side Unaffected side Ratio
Shoulder flexion strength (kg)
Female 11.32 (7.64, 14.64) 12.38 (8.20, 14.86) 0.97 (0.83, 1.03)
Male 20.19 (13.80, 25.25) 20.56 (16.02, 27.48) 1.01 (0.81, 1.21)
Flexion Extension Ratio
Neck strength (kg)
Female 5.27 (4.26, 7.82) 9.09 (7.74, 10.20) 0.63 (0.50, 0.74)
Male 9.09 (6.35, 10.80) 11.43 (8.41, 15.31) 0.81 (0.51, 0.95)
Q1 quartile one, Q3 quartile three, AROM active range of motion
a Number (%) of people unable to reach opposite scapula or worse (categories 1 to 4)
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Table 4 Generalised linear models for the Neck Dissection Impairment Index (NDII), Quick Disabilities of the Arm, Shoulder and Hand
(QuickDASH), and Neck Disability Index (NDI)
Explanatory variable Model 1
NDII (link—identity)
Model 2
QuickDASH (link—log)
Model 3
NDI (link—log)
Coefficient (95% CI); p value Coefficient (95% CI); p value Coefficient (95% CI); p value
Physical factors:
AROM shoulder flexionc 0.56 (0.24, 0.86); < 0.001* n/a − 0.01 (− 0.02, 0.00); 0.05*
AROM shoulder abductionc − 0.10 (− 0.33, 0.12); 0.37 − 9.46 (− 21.33, 2.40)a; 0.12 n/a
AROM shoulder HBB
(reference = category 0)d
Category 1 2.04 (− 8.10, 12.27); 0.70 0.47 (0.04, 0.89); 0.03* 0.59 (0.14, 1.03); < 0.01*
Category 2 0.40 (− 16.89, 17.68); 0.96 0.65 (− 0.48, 1.79); 0.26 1.26 (0.61, 1.91); < 0.001
Category 3 3.59 (− 17.83, 25.01); 0.74 0.51 (− 0.01, 1.04); 0.05 0.72 (0.08, 1.35); 0.03*
Category 4 − 37.21 (− 64.19, − 10.22);
< 0.01*
1.08 (0.49, 1.66); < 0.001* 2.36 (1.05, 3.66); < 0.001*
Strength shoulder flexion ratio 27.19 (11.72, 42.67); < 0.01* − 1.01 (− 1.70, − 0.33);
< 0.001*
− 0.17 (− 0.73, − 0.39); 0.54
AROM neck extension 0.18 (− 0.15, 0.52); 0.29 n/a − 0.01 (− 0.03, 0.00); 0.07
AROM neck rotation to the affected side 0.11 (− 0.30, 0.53); 0.60 n/a 2.40 (− 14.93, 19.73)a; 0.79
AROM neck rotation to the unaffected side 0.42 (− 0.08, 0.94); 0.11 n/a n/a
Scapular resting positionc n/a n/a 7.39 (− 33.48, 48.26)a; 0.72
Patient factors:
Age at surgery 0.85 (0.56, 1.13); < 0.001* − 22.78 (− 46.97, 1.42)a; 0.07 − 0.05 (− 0.07, − 0.03);
< 0.001*
Sex (reference = female)
Male − 4.72 (− 12.89, 3.46); 0.26 − 0.13 (− 0.58, 0.32); 0.59 0.09 (− 0.27, 0.47); 0.62
Body mass index − 1.84 (− 2.82, − 0.85); < 0.001* − 0.01 (− 0.07, 0.05); 0.76 0.05 (0.01, 0.08); < 0.01*
Surgical factors:
Time since surgery − 2.78 (− 10.1, 4.52)a; 0.46 4.39 (− 25.34, 34.13)b; 0.77 − 23.29 (− 55.53, 8.94)b; 0.16
Type of neck dissection (reference = unilateral
SND)
Unilateral MRND − 3.00 (− 11.81, 5.81); 0.50 − 0.35 (− 0.83, 0.12); 0.15 − 0.13 (− 0.81, 0.54); 0.70
Bilateral ND − 12.49 (− 24.69, − 0.29); 0.05* 0.56 (− 0.44, 1.57); 0.27 0.17 (− 0.28, 0.62); 0.46
Status of accessory nerve (reference = preserved)
Sacrificed 9.85 (− 4.17, 23.88); 0.17 − 0.36 (− 1.00, 0.28); 0.27 − 0.92 (− 1.50, − 0.33);
< 0.01*
History of ND (reference = no)
Yes − 17.00 (− 29.37, − 4.62);
< 0.01*
n/a n/a
Adjuvant therapy (reference = ND only)
ND with post-operative XRT − 9.82 (− 22.47, 2.82); 0.13 n/a 0.40 (− 0.23, 1.02); 0.21
ND with post-operative CXRT − 21.46 (− 37.57, − 5.35);
< 0.01*
n/a 0.71 (0.10, 1.32); 0.02*
Other − 14.86 (− 30.08, 0.37); 0.06 n/a − 0.87 (− 1.83, 0.08); 0.07
Tumour-related factors
T stage (reference = T0)
T1 − 17.56 (− 37.75, 2.63); 0.09 0.09 (− 0.56, 0.74); 0.78 0.62 (0.24, 1.01); < 0.01*
T2 8.93 (− 6.61, 24.48); 0.26 − 0.44 (− 1.30, 0.42); 0.31 − 0.18 (− 0.82, 0.46); 0.58
T3 2.19 (− 21.93, 26.31); 0.86 − 0.64 (− 2.12, − 0.84); 0.40 0.35 (− 0.40, 1.10); 0.36
T4 7.94 (− 6.52, 22.40); 0.28 − 0.73 (− 1.62, 0.15); 0.11 − 0.49 (− 0.88, − 0.10); 0.01*
Tis 0.20 (− 17.02, 17.42); 0.98 − 0.55 (− 1.34, 0.24); 0.17 0.47 (− 0.24, 1.19); 0.20
Tx 7.46 (− 9.04, 23.95); 0.38 − 0.26 (− 1.58, 1.07); 0.70 − 0.02 (− 0.94, 0.90); 0.97
No T stage available 8.14 (− 6.09, 22.36); 0.26 − 0.76 (− 1.36, − 0.16); 0.01* − 0.71 (− 1.55, 0.14); 0.10
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This study has described key factors associated with neck
disability, which have been identified as underreported in a
recent systematic review [14]. Previous studies of patients
with HNC have reported similar NDI scores to the present
study, but were much smaller and not limited to a surgical
population [50] [51]. In contrast, the NDI has been used ex-
tensively in the musculoskeletal neck pain literature [21] to
measure self-reported neck disability. Younger patients with
musculoskeletal neck pain often have less neck disability [52],
which is in contrast to the present study where younger age
was associated with greater neck disability. Accessory nerve
sacrifice was associated with less neck disability in the model
for the NDI; however, this finding is likely spurious and
should be interpreted with caution as the number of individ-
uals with accessory nerve sacrifice was small (n = 5). Overall,
the results demonstrate that the neck as well as the shoulder
ought to be considered as a source of dysfunction in patients
managing the long-term effects of this procedure.
Other patient populations with musculoskeletal pain have
also demonstrated altered axioscapular motor function during
an upper limb task. Elite swimmers with shoulder pain
displayed increased anterior scalene electromyography
(EMG) activity compared with asymptomatic elite swimmers
[53]. In addition, individuals with mechanical neck pain dem-
onstrated altered scapular kinematics during shoulder eleva-
tion, and failed to demonstrate any adaptation in muscular
activation to neck extensor muscle fatigue (unlike healthy
control subjects) [54]. With regard to experimentally induced
pain, localised and referred pain from hypertonic saline injec-
tion into the splenius capitis muscle has resulted in changes to
trunk and axioscapular muscle EMG activity (including re-
duced upper trapezius activity) during elevation of the shoul-
der in the scapular plane [55]. It is clear from this evidence that
there is a biomechanical relationship between the cervical
spine and the shoulder, and that musculoskeletal pain can
affect motor activation across this body region. Changes to
muscular activity during functional tasks have been proposed
to be a protective mechanism for painful structures [56].
Therefore, the reduction in shoulder flexion AROM found in
this study may be a consequence of neck or shoulder pain, or a
cause of neck or shoulder pain that, in either circumstance, is
reflected in increased levels of self-perceived pain-related dis-
ability of the upper limb and neck.
Participants with a history of unilateral RND were not
included in the statistical analyses within this study because
this sub-group was small (n = 3). The HRQOL and disabil-
ity scores for these n = 3 participants were not consistently
poor (NDII range 60 to 97.5; QuickDASH range 6 to 20;
NDI range 0 to 20). It is therefore not known from the
present data if unilateral RND is associated with worse
HRQOL or self-reported disability in comparison to unilat-
eral SND. Previous research has demonstrated associations
between RND and reduced shoulder abduction AROM
[57, 58] and strength [39], shoulder and neck pain [41],
and shoulder function measured with the Constant
Shoulder Score [59]. However, with the rise of selective
and super-selective ND [60], the frequency of RND is de-
creasing. Consequently, obtaining a better understanding of
the long-term outcomes of patients who undergo more se-
lective procedures is more clinically relevant in the modern
Head and Neck Clinic.
There are several limitations and strengths of the present
study that may influence the interpretation of the aforemen-
tioned findings. Measuring shoulder strength in a neutral po-
sition (beside the trunk) may have masked findings of reduced
strength in more elevated ranges; however, this position was
chosen in order to ensure all participants could complete the
test. Recording muscular strength objectively is novel for this
patient population, as previous studies have preferred the sub-
jective manual muscle testing approach [6, 61, 62]. The use of
Table 4 (continued)
Explanatory variable Model 1
NDII (link—identity)
Model 2
QuickDASH (link—log)
Model 3
NDI (link—log)
Pathology (reference = SCC)
PTC 4.28 (− 11.82, 20.37); 0.60 n/a − 0.04 (− 0.67, 0.59); 0.99
Melanoma − 0.61 (− 16.40, 15.19); 0.94 n/a 0.06 (− 0.71, 0.83); 0.88
Other 11.42 (− 5.30, 28.14); 0.18 n/a 0.18 (− 0.92, 1.28); 0.75
NDII Neck Dissection Impairment Index, QuickDASH Quick Disabilities of the Arm, Shoulder and Hand, NDI Neck Disability Index, AROM active
range of motion, HBB hand-behind-back, SND selective neck dissection, MRND modified radical neck dissection, ND neck dissection, XRT radiation
therapy, CXRT chemoradiation therapy, SCC squamous cell carcinoma, PTC papillary thyroid carcinoma
a Scientific notation used: this result is ×10−3
b Scientific notation used: this result is ×10−5
c This outcome refers to the affected side
d Categories within the HBB are as follows: 0 = hand reaches < 5 cm away from opposite scapula; 1 = hand reaches 6–15 cm away from opposite scapula;
2 = hand reaches the opposite iliac crest; 3 = hand reaches the buttock; 4 = hand unable to pass behind the trunk. *p < 0.05
Where coefficients are not displayed (‘n/a’), the most parsimonious model did not contain this explanatory variable
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strength ratios has limitations in the presence of bilateral or
widespread strength deficits; therefore, the analysis
considered both strength ratios and raw strength data for
potential inclusion in the linear models. Another limitation
of the study was that participants were from one geographical
region in an industrialised nation with accessible health
services, and patients from dissimilar societies may not
report comparable levels of dysfunction. Regarding rehabili-
tation, there may have been individual variation in the
treatment received depending on presenting signs and symp-
toms during the early recovery period that may have affected
disability outcomes, but this was considered beyond the scope
of the present investigation. The ever present risk of survivor-
ship bias may have also influenced the participant sample in
this cross-sectional study of patients with a life-limiting ill-
ness, in that the conclusions drawn may not reflect the lived
experiences of those patients who had passed away before this
study was conducted. Despite this, the findings of this
study are informative to the prevention and management of
neck and upper limb-related disability and HRQOL in HNC
survivors.
Conclusion
Patients can experience reduced HRQOL and upper limb and
neck disability following ND. Undergoing a bilateral ND is
associated with worse quality of life but not upper limb or
neck disability. Concurrent CXRT appears to have a negative
effect on quality of life and neck disability. The patient-,
tumour- and treatment-related factors associated with poorer
HRQOL and greater disability of the head and neck identified
in the present study may assist clinical teams in identifying
patients who may require referral for rehabilitative
interventions.
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